ACAAI: 2013 to 2023 Saw Rise in Pediatric Psych Referrals Tied to Food Allergies
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 28, 2024 -- The number of pediatric psychology referrals for issues related to food allergy increased dramatically during the past decade, according to a study presented at the annual meeting of the American College of Allergy, Asthma & Immunology, held from Oct. 24 to 28 in Boston.
Andriana La Mantia, M.D., from the Nationwide Children's Hospital in Columbus, Ohio, and colleagues characterized the use of psychology services for food allergy-related anxiety in children. The analysis included outpatient pediatric psychology referrals at a tertiary care center between 2013 and 2023.
The researchers found that of the 250 patients (median age, 9.5 years), 88 percent were referred for food allergy-related concerns, with an average of 2.1 allergens per patient. More than half (53 percent) had prior documented anaphylaxis. More than two-thirds (69 percent) had food-related anxiety, and 12 percent had quality-of-life impairment prompting referrals. Six in 10 patients who received psychology referrals completed at least one appointment, with an average of 5.5 follow-up appointments attended during the subsequent year. During the study period, there was an 11-fold increase in food allergy-related anxiety referrals placed, with a single-year >50 percent increase in 2023 versus yearly referrals from 2018 to 2022.
"The number of pediatric psychology referrals for issues related to food allergy increased dramatically over the past decade," the authors write. "Expansion of these services will be important to meet the needs of our patients."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-29 06:00
Read more
- EPA Finalizes Tough New Standards on Lead Paint Dust
- FDA Appoints New Head of Medical Devices
- Risk for Mortality Up With Low Income in Type 2 Diabetes
- Marijuana Use Has Fallen 'Dramatically' Among U.S. Teens
- Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
- Expanded Admission Screening Protocol for Candida Auris Beneficial
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions